Medical Device
Manufacturing
THE TRADE PAPER OF THE FACTORY FLOOR
Z-2277-2026Class I

Spinocan Spinal Needle procedure kits: Material Description (Material Number): Spinocan 26 Ga. x 3-1/2 in...

B Braun Medical Inc / initiated 2026-05-06 / Open, Classified / root cause: manufacturing process

B Braun Medical Inc began a recall of Spinocan Spinal Needle procedure kits: Material Description (Material Number): Spinocan 26 Ga. x 3-1/2 in. (90 mm), Bupivacaine 0.75% with Dextrose 8.25% Tray... on . FDA classified it as Class I and gives the reason as "These procedure kits contain Bupivacaine Hydrochloride in Dextrose Injection, USP. The manufacturer of the Bupivacaine, Huons Co, Ltd., has issued a voluntary recall due to potential quality issues identified during a...". As of , the recall status on record is Open, Classified, and MDM tags the root cause as manufacturing process.

Recall record

Recall number
Z-2277-2026
Classification
Class I
Status
Open, Classified
Initiated
Posted
Recalling firm
B Braun Medical Inc
Product
Spinocan Spinal Needle procedure kits: Material Description (Material Number): Spinocan 26 Ga. x 3-1/2 in. (90 mm), Bupivacaine 0.75% with Dextrose 8.25% Tray (Kit) (333201); Spinocan 25 Ga. x 3-1/2 in. (90 mm), Bupivacaine 0.75% with Dextrose 8.25% Tray (Kit) (333211); Spinocan 22 Ga. x 3-1/2 in. (90 mm), Bupivacaine 0.75% with Dextrose 8.25% Tray (Kit) (333231)
Product code
OFU Spinal Anesthesia Kit
Reason for recall
These procedure kits contain Bupivacaine Hydrochloride in Dextrose Injection, USP. The manufacturer of the Bupivacaine, Huons Co, Ltd., has issued a voluntary recall due to potential quality issues identified during a recent FDA manufacturing facility inspection.
Root cause tag
manufacturing process
FDA root cause
Under Investigation by firm
Action
On May 6, 2026, URGENT MEDICAL DEVICE RECALL were sent to customers. Actions to be taken: - Check inventory for affected product and return to B Braun. The return process will begin when B Braun received the Acknowledgement Form.) - If you are a distributor and have further distributed the product, please forward this notice to your consignees. This recall is to be extended to the hospital/healthcare facility level. Should there be any questions, comments, or concerns, please feel free to contact us via email at [email protected] or via phone at 844-903-6417 Monday through Friday, 8:00am-5:00pm EST.
Quantity in commerce
16,080 units
Distribution
US Nationwide distribution.
Product codes and lots
1. Material: 333201; UDI-DI Primary/Unit of Use: 4046964179365/4046964179358; Batch Number: 0061976152; 2. Material: 333211; UDI-DI Primary/Unit of Use: 4046964179389/4046964179372; Batch numbers: 0061965729, 0061971323, 0061972572; 3. Material: 333231; UDI-DI Primary/Unit of Use: 4046964179488/4046964179471; Batch Number: 0061978177;

Enforcement reports

One row per recalled product line
FDA enforcement reports joined to recall event Z-2277-2026
Recall numberClassStatusVoluntary or mandatedReport dateClassified
Z-2276-2026Class IOngoingVoluntary: Firm initiated
Z-2277-2026Class IOngoingVoluntary: Firm initiated
Z-2278-2026Class IOngoingVoluntary: Firm initiated